Assay platform for clinically relevant metallo-β-lactamases. by van Berkel, S, Brem, J, Rydzik, A, Salimraj, R, Cain, R, Verma, A, Owens, R, Fishwick, C, Spencer, J, Schofield, C

Structure guided development of potent reversibly binding penicillin binding protein inhibitors. by Woon, E, Zervosen, A, Sauvage, E, Simmons, K, Zivec, M, Inglis, SR, Fishwick, C, Gobec, S, Charlier, P, Luxen, A, Schofield, C

Structural/mechanistic insights into the efficacy of nonclassical β-lactamase inhibitors against extensively drug resistant Stenotrophomonas maltophilia clinical isolates by Calvopiña, K, Hinchliffe, P, Brem, J, Heesom, K, Johnson, S, Cain, R, Lohans, C, Fishwick, C, Schofield, C, Spencer, J, Avison, M

Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates by Brem, J, Cain, R, Cahill, S, McDonough, M, Clifton, I, Jiménez-Castellanos, J, Avison, M, Spencer, J, Fishwick, C, Schofield, C

Cyclic Boronates Inhibit All Classes of β-Lactamase. by Cahill, S, Cain, R, Wang, D, Lohans, C, Wareham, D, Oswin, H, Mohammed, J, Spencer, J, Fishwick, C, McDonough, M, Schofield, C, Brem, J

Studies on the inhibition of AmpC and other β-lactamases by cyclic boronates by Cahill, S, Tyrrell, J, Navratilovac, I, Calvopiña, K, Robinson, S, Lohans, C, McDonough, M, Cain, R, Fishwick, C, Avison, M, Walsh, T, Schofield, C, Brem, J

In silico fragment based design identifies subfamily B1 metallo-β-lactamase inhibitors by Cain, R, Brem, J, Zollman, D, McDonough, M, Johnson, R, Spencer, J, Makena, A, Abboud, M, Cahill, S, Lee, S, McHugh, P, Schofield, C, Fishwick, C